Agilent Technologies, Inc. $A Stock: William Blair Investment Management LLC Trims Position

William Blair Investment Management LLC lowered its holdings in shares of Agilent Technologies, Inc. (NYSE:A – Free Report) by 4.8% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,225,480 shares of the medical research company’s stock after selling 61,785 shares during the period. William Blair Investment Management LLC owned 0.43% of Agilent Technologies worth $211,162,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. State Street Corp grew its position in Agilent Technologies by 0.7% during the 2nd quarter. State Street Corp now owns 12,854,230 shares of the medical research company’s stock worth $1,710,658,000 after purchasing an additional 89,598 shares during the last quarter. Wellington Management Group LLP raised its holdings in shares of Agilent Technologies by 2.7% in the second quarter. Wellington Management Group LLP now owns 7,454,686 shares of the medical research company’s stock valued at $990,206,000 after buying an additional 198,253 shares during the last quarter. Deutsche Bank AG raised its holdings in shares of Agilent Technologies by 17.1% in the second quarter. Deutsche Bank AG now owns 7,008,634 shares of the medical research company’s stock valued at $930,957,000 after buying an additional 1,024,516 shares during the last quarter. Bank of New York Mellon Corp raised its holdings in shares of Agilent Technologies by 87.4% in the second quarter. Bank of New York Mellon Corp now owns 5,233,964 shares of the medical research company’s stock valued at $695,227,000 after buying an additional 2,440,360 shares during the last quarter. Finally, Dimensional Fund Advisors LP boosted its stake in shares of Agilent Technologies by 9.6% during the first quarter. Dimensional Fund Advisors LP now owns 2,108,764 shares of the medical research company’s stock worth $240,336,000 after buying an additional 185,223 shares during the period. Institutional investors and hedge funds own 87.41% of the company’s stock.

Wall Street Analysts Forecast Growth

A has been the topic of a number of research reports. Weiss Ratings raised Agilent Technologies from a “hold (c+)” rating to a “buy (b-)” rating in a report on Thursday, October 8th. Rothschild & Co Redburn boosted their price target on Agilent Technologies from $160.00 to $180.00 and gave the company a “buy” rating in a research report on Thursday, August 27th. Robert W. Baird upped their price objective on Agilent Technologies from $180.00 to $195.00 and gave the company an “outperform” rating in a research note on Thursday, October 8th. UBS Group increased their price objective on Agilent Technologies from $165.00 to $180.00 in a research report on Tuesday, October 13th. Finally, Royal Bank Of Canada lifted their target price on Agilent Technologies from $155.00 to $185.00 and gave the company an “outperform” rating in a research note on Thursday, August 27th. Eighteen research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $181.45.

Check Out Our Latest Analysis on Agilent Technologies

Insider Buying and Selling

In other Agilent Technologies news, Director Mikael Dolsten sold 634 shares of Agilent Technologies stock in a transaction that occurred on Friday, September 4th. The stock was sold at an average price of $151.38, for a total value of $95,974.92. Following the sale, the director owned 4,924 shares of the company’s stock, valued at approximately $745,395.12. The trade was a 11.41% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.17% of the stock is currently owned by insiders.

Agilent Technologies Stock Up 0.0%

Shares of Agilent Technologies stock opened at $173.99 on Monday. The company has a market cap of $49.05 billion, a P/E ratio of 34.25, a PEG ratio of 2.56 and a beta of 1.24. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.56 and a current ratio of 2.05. Agilent Technologies, Inc. has a one year low of $108.35 and a one year high of $182.99. The firm has a fifty day moving average of $168.41 and a two-hundred day moving average of $138.19.

Agilent Technologies (NYSE:A – Get Free Report) last released its earnings results on Wednesday, August 26th. The medical research company reported $1.62 EPS for the quarter, topping the consensus estimate of $1.49 by $0.13. The company had revenue of $1.88 billion during the quarter, compared to analysts’ expectations of $1.84 billion. Agilent Technologies had a net margin of 19.53% and a return on equity of 24.45%. The business’s revenue was up 8.1% on a year-over-year basis. During the same quarter last year, the business earned $1.37 EPS. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. On average, analysts forecast that Agilent Technologies, Inc. will post 6.20 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, October 28th. Investors of record on Tuesday, October 6th were given a $0.2550 dividend. The ex-dividend date was Tuesday, October 6th. This represents a $1.02 dividend on an annualized basis and a yield of 0.6%. Agilent Technologies’s dividend payout ratio (DPR) is presently 20.08%.

Agilent Technologies Company Profile

(Free Report)

Agilent Technologies develops and supplies instruments, software, services and consumables used in laboratories and manufacturing operations. Its offerings support applications in life sciences, diagnostics, chemical analysis, food safety, environmental testing and pharmaceutical research. The company serves customers worldwide, including pharmaceutical and biotechnology companies, clinical and academic laboratories, and organizations in the chemical, energy and food industries. Its services include laboratory equipment maintenance, technical support and related workflow solutions.

Read More

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A – Free Report).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.